The recent arrival of Tirzepatide 40mg represents a possibly significant advancement in the treatment of type 2 the illness. This drug builds upon the prior success of lower dosages , showing promising results in improving blood glycemic control and promoting weight loss . Researchers are investigating its full effect on heart outcomes and associat